Cargando…

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?

Detalles Bibliográficos
Autores principales:	Sado, Daniel, Maestrini, Viviana, White, Steven K, Piechnik, Stefan K, Robson, Matthew D, Flett, Andrew, Tome Esteban, Maria T, Pantazis, Antonios, McKenna, William J, Neubauer, Stefan, Elliott, Perry, Moon, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559813/ http://dx.doi.org/10.1186/1532-429X-15-S1-P140

Ejemplares similares

A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy
por: Flett, Andrew, et al.
Publicado: (2013)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy()
por: Flett, Andrew S., et al.
Publicado: (2015)

Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance
por: Quarta, Giovanni, et al.
Publicado: (2013)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death
por: Dass, Sairia, et al.
Publicado: (2012)

Arrhythmogenic right ventricular cardiomyopathy mimics: clinical impact of cardiovascular magnetic resonance
por: Quarta, Giovanni, et al.
Publicado: (2012)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

Single breath-hold Vd(m) calculation as good as multi breath-hold technique in Equilibrium Contrast CMR
por: Sado, Daniel, et al.
Publicado: (2012)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study
por: Schoonvelde, Stephan A. C., et al.
Publicado: (2023)

Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation
por: Elsouri, Kawther N, et al.
Publicado: (2023)

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR
por: Fontana, Marianna, et al.
Publicado: (2012)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias
por: Ariga, Rina, et al.
Publicado: (2019)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
por: Réant, Patricia, et al.
Publicado: (2023)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Not all LGE is the same. Scar contrast volume of distribution is lower in HCM than in infarction
por: Treibel, Thomas A, et al.
Publicado: (2012)

Foreword to the Special Issue: HCM in 2018
por: Elliott, Perry
Publicado: (2018)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

The evolution and clinical importance of scar in hypertrophic cardiomyopathy - a 7 year CMR follow-up study
por: Quarta, Giovanni, et al.
Publicado: (2011)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model
por: Bhattacharya, Moumita, et al.
Publicado: (2021)

The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM
por: Kittleson, Mark D, et al.
Publicado: (2021)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM)
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2016)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
por: Stec, Maria, et al.
Publicado: (2023)

Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
por: Montag, J., et al.
Publicado: (2018)

Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration
por: Captur, Gaby, et al.
Publicado: (2014)

Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
por: Kübler, J., et al.
Publicado: (2021)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
por: Lopes, Luis R, et al.
Publicado: (2013)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
por: Flett, Andrew S, et al.
Publicado: (2009)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rc2d26djfnme9ph8esuh14u2e2